| Name | 6-Chloro-9-(2,3,5-tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-9H-purine |
|---|---|
| Synonyms | (2R,3R,4R,5R)-5-[(benzoyloxy)methyl]-2-(6-chloro-9H-purin-9-yl)-3-methyltetrahydrofuran-3,4-diyl dibenzoate |
| Description | 6-Chloro-9-(2,3,5-tri-O-benzoyl-2-C-methyl-beta-D-ribofuranosyl)-9H-purine dibenzoate is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.41 |
|---|---|
| Boiling Point | 757.022ºC at 760 mmHg |
| Molecular Formula | C32H25ClN4O7 |
| Molecular Weight | 613.02 |
| Exact Mass | 612.14100 |
| PSA | 131.73000 |
| LogP | 5.07540 |
| Vapour Pressure | 0mmHg at 25°C |
| Index of Refraction | 1.667 |
| Precursor 2 | |
|---|---|
| DownStream 3 | |